Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights
Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...
Building a Scientific Collaborative Space - Insights
Combining innovative Mayo Clinic laboratories with medical businesses and creative start-up companies will help Rochester—and benefit patients.
Winter Activities: Safety Tips - Insights
Here in Minnesota, we have entered into the time of year that is either loved or hated by Minnesotans: winter. In honor of Winter Hazard Awareness Week, November 6–10, Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, suggests resources...
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Frequently asked questions - Insights
Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
Connect with us at the American Academy of Neurology Annual Meeting to learn how our evaluations can inform your clinical practice.
Seeking, and finding, answers, comfort, and hope: Joe Mondloch - Insights
Joe Mondloch and his wife Sue have existed in a grey area of uncertainty due to the unpredictable autoimmune neurological illness Joe has lived with for the last seven years. Rare, incurable, and debilitating, the newly classified disorder...